Portal de Periódicos da CAPES

Reconsidering the Trade-offs of Prostate Cancer Screening

2020; Massachusetts Medical Society; Volume: 382; Issue: 25 Linguagem: Inglês

10.1056/nejmsb2000250

1533-4406

Jonathan E. Shoag, Yaw A. Nyame, Roman Gulati, Ruth Etzioni, Jim C. Hu,

Global Cancer Incidence and Screening

Shoag and colleagues review the long-term results of PSA screening from randomized trials and raise questions about whether the risk–benefit ratio is as strongly in favor of risk over benefit as currently gauged. The decline in PSA screening appears to have been precipitated in part by misinterpretations of data from randomized trials.